These levels of S-specific Abs matched or exceeded most samples from a panel of 30 COVID-19 human convalescent sera (HCS) from Washington state and the benchmark 20/130 COVID-19 plasma from National Institute for Biological Standards and Control (NIBSC) (Figure 4A–B; see STAR Methods). This evidence concerns the gene DDX41 and COVID-19.